aim
studi
correl
respiratori
virom
copd
patient
found
mng
qpcr
clinic
data
patient
copd
includ
bergen
copd
exacerb
studi
bce
bergen
norway
patient
live
haukeland
univers
hospit
district
baselin
data
taken
first
visit
stabl
state
includ
amongst
other
exacerb
histori
medic
comorbid
spirometri
global
initi
chronic
obstruct
lung
diseas
gold
categoris
patient
given
telephon
number
studi
nurs
would
contact
case
exacerb
patient
exacerb
accord
predefin
set
symptom
schedul
appoint
studi
physician
next
work
day
exacerb
nasopharynx
swab
sampl
two
differ
marker
sever
exacerb
score
exacerb
control
visit
schedul
studi
period
patient
least
one
exacerb
total
exacerb
includ
bce
exacerb
sampl
test
current
studi
nasopharyng
sampl
frozen
store
total
nasopharyng
sampl
patient
time
exacerb
select
base
avail
sampl
outsid
current
focu
sent
leiden
univers
medic
center
netherland
test
viral
respiratori
panel
cover
multiplex
realtim
pcr
qpcr
develop
laboratori
consist
coronaviru
coronaviru
coronaviru
coronaviru
influenza
influenza
b
human
metapneumoviru
parainfluenza
differenti
probe
respiratori
syncyti
viru
rhinoviru
total
nucleic
acid
na
extract
directli
clinic
sampl
use
total
nucleic
acid
extract
kit
magnapur
lc
system
roch
diagnost
almer
netherland
output
eluat
nucleic
acid
amplif
detect
realtim
pcr
perform
biorad
thermocycl
use
primer
probe
condit
describ
previous
cq
valu
normal
use
fix
baselin
fluoresc
threshold
metagenom
protocol
use
describ
optim
simultan
rna
dna
detect
previous
short
intern
control
equin
arter
viru
eav
rna
phocid
phhv
dna
kindli
provid
prof
dr
hgm
niester
netherland
spike
viru
transport
medium
nasopharyng
swab
store
nucleic
acid
extract
directli
clinic
sampl
use
magnapur
dna
viral
na
small
volum
extract
kit
magnapur
system
roch
diagnost
almer
netherland
output
eluat
updat
version
isol
method
use
qpcr
test
previous
extract
buffer
use
neg
control
extract
librari
prepar
sequenc
librari
prepar
nucleic
acid
use
use
direct
rna
librari
prep
kit
sever
inhous
adapt
manufactur
protocol
order
enabl
simultan
detect
dna
rna
follow
step
omit
poli
mrna
captur
isol
rrna
deplet
dnase
treatment
step
result
singl
tube
per
sampl
throughout
librari
prepar
contain
dna
rna
metagenom
sequenc
perform
illumina
nextseq
sequenc
system
illumina
san
diego
ca
usa
approxim
million
bp
pairedend
read
per
sampl
obtain
qualiti
preprocess
sequenc
read
taxonom
classifi
centrifug
use
index
construct
ncbi
refseq
taxonomi
databas
access
februari
refer
nucleotid
sequenc
virus
bacteria
archaea
fungi
parasit
protozoa
read
multipl
best
match
uniqu
assign
lowest
common
ancestor
k
centrifug
set
previous
valid
neg
posit
result
confirm
use
genomedetect
websit
version
access
decemb
horizont
coverag
determin
use
genomedetect
read
count
normal
divid
rawread
count
total
number
read
sampl
averag
genom
size
multipli
achiev
comprehens
read
count
order
magnitud
raw
read
count
sampl
dubiou
inconclus
classif
result
de
novo
assembl
perform
preprocess
short
read
assign
higher
taxonom
level
suspect
viral
target
extract
de
novo
assembl
spade
version
longer
stretch
contigu
sequenc
contig
result
contig
run
blast
ncbi
nucleotid
nt
databas
access
use
blastn
identif
put
target
sequenc
read
origin
sampl
map
identifi
best
blast
hit
confirm
use
bwa
softwar
packag
sensit
specif
posit
neg
predict
valu
calcul
base
pcr
posit
pcr
neg
target
result
sampl
correl
qpcr
cq
valu
logarithm
normal
number
mng
viral
read
test
popul
pearson
correl
coeffici
potenti
correl
mng
data
clinic
variabl
test
follow
cq
valu
viral
read
clinic
paramet
exacerb
sever
durat
exacerb
decreaseincreas
forc
expiratori
volum
second
control
visit
compar
baselin
test
oneway
anova
kruskalw
test
appropri
depend
distribut
comparison
percentag
phage
viral
read
subtract
intern
control
eav
phhv
read
mng
viru
posit
sampl
neg
sampl
test
mannwhitney
u
test
comparison
clinic
paramet
kruskalw
test
divers
virom
differ
patient
group
character
shannon
divers
index
h
test
welch
two
sampl
ttest
statist
analys
perform
use
ibm
spss
statist
version
softwar
window
consid
statist
signific
prior
inclus
subject
receiv
written
oral
inform
sign
inform
consent
bce
studi
approv
region
ethic
committe
western
norway
rekvest
case
number
perform
studi
includ
mng
approv
medic
ethic
review
committe
leiden
univers
medic
center
cme
number
addit
consent
necessari
total
patient
exacerb
includ
median
one
exacerb
per
patient
rang
baselin
patient
characterist
exacerb
characterist
shown
tabl
respect
sampl
test
posit
inhous
pcr
rhinoviru
posit
three
influenza
two
coronaviru
one
coronaviru
two
parainfluenza
one
parainfluenza
cq
valu
rang
tabl
median
million
sequenc
read
per
sampl
obtain
million
read
approxim
homo
sapien
read
bacteri
viral
tabl
median
read
could
assign
sequenc
centrifug
index
databas
ncbi
refseq
sensit
specif
predict
valu
mng
calcul
base
pcr
posit
pcr
neg
target
result
sampl
normal
read
count
tabl
calcul
made
use
differ
cutoff
valu
respect
normal
read
count
cutoff
sensit
specif
posit
predict
valu
ppv
increas
neg
predict
valu
npv
cutoff
level
roc
curv
fig
use
youden
index
demonstr
optim
sensit
specif
achiev
use
cutoff
read
respect
mng
provid
addit
type
data
compar
qpcr
rhinovirus
detect
mng
rhinoviru
rhinoviru
b
rhinoviru
c
three
influenza
virus
assign
strain
mng
order
analys
semiquantit
qualiti
mng
assay
number
normal
sequenc
read
log
map
qpcr
target
virus
speci
level
obtain
mng
compar
cq
valu
qpcr
signific
neg
correl
found
fig
pearson
correl
coeffici
p
follow
marker
test
potenti
associ
clinic
sever
exacerb
exacerb
sever
selfreport
exacerb
sever
length
exacerb
decreaseincreas
control
visit
compar
baselin
mng
pathogen
posit
versu
neg
exacerb
qpcr
target
number
normal
read
log
cutoff
read
differ
target
virus
speci
level
correl
found
marker
differ
diseas
sever
paramet
result
shown
overal
proport
normal
read
count
viral
famili
exclud
eav
phhv
control
read
cutoff
read
detect
mng
per
patient
shown
fig
patient
viral
pathogen
pcr
target
virus
significantli
reduc
proport
bacteriophag
compar
patient
without
viral
bacteriophag
respect
p
bacteriophag
read
vs
viral
read
normal
read
exclud
eav
phhv
control
read
shannon
divers
score
bacteriophag
normal
read
cutoff
read
compar
copd
exacerb
viral
aetiolog
pcr
posit
versu
neg
patient
fig
shannon
divers
normal
read
exclud
intern
control
signific
lower
viral
read
p
eukaryot
virus
p
patient
viral
pathogen
pcr
target
virus
posit
signific
associ
found
divers
score
percentag
bacteriophag
follow
paramet
diseas
sever
length
exacerb
number
exacerb
studi
period
differ
gold
stage
smoke
crp
level
viru
speci
result
shown
preval
phyla
proteobacteria
firmicut
actinobacteria
bacteroidet
see
fig
normal
bacteri
read
count
preval
phyla
significantli
differ
patient
pcrtarget
viru
posit
pcrtarget
neg
patient
pathogen
bacteri
speci
detect
abund
bacteri
read
h
influenza
five
sampl
catarrhali
sampl
pneumonia
one
sampl
aureu
one
sampl
appar
associ
bacteriophag
found
high
abund
bacteriophag
associ
copd
exacerb
viral
caus
raw
sequenc
data
sampl
remov
human
read
deposit
sequenc
read
archiv
databas
http
wwwncbinlmnihgov
access
number
studi
respiratori
virom
patient
copd
exacerb
analys
mng
qpcr
combin
clinic
data
incid
viral
pathogen
mng
qpcr
mng
fail
detect
one
rhinoviru
low
load
cq
pcr
fail
detect
one
betacoronaviru
read
due
one
limit
pcr
ie
inhibit
amplif
one
addit
viral
pathogen
present
respiratori
pcr
panel
detect
herp
simplex
viru
found
other
associ
copd
incid
viral
pathogen
compar
previou
public
viral
pathogen
highest
incid
rhinoviru
follow
influenza
coronavirus
parainfluenza
virus
interestingli
subtyp
data
readili
avail
mng
accentu
high
resolut
mng
rhinoviru
rv
speci
c
frequent
follow
rvb
rvc
first
identifi
associ
high
symptom
burden
children
asthmat
recent
asthmarel
cadherinrel
famili
member
gene
variant
associ
greater
rvc
receptor
display
pulmonari
cell
surfac
children
adult
associ
higher
suscept
sever
virustrigg
asthma
episod
line
romeroespinoza
et
al
detect
predominantli
rvc
children
acut
asthma
exacerb
mng
signific
rvc
infect
adult
popul
less
well
studi
although
rvc
previous
associ
exacerb
copd
knowledg
date
polymorph
yet
found
associ
copd
sensit
specif
posit
neg
predict
valu
mng
high
respect
encount
cutoff
read
detect
limit
approxim
cq
high
neg
predict
valu
implic
potenti
mng
exclud
preval
viral
respiratori
infect
one
test
potenti
exclud
infecti
caus
viral
bacteri
would
signific
consequ
start
andor
continu
antimicrobi
end
spectrum
immunemodul
treatment
normal
viral
speci
sequenc
read
count
might
give
indic
viral
burden
clinic
relev
detect
viru
although
dataset
could
find
correl
diseas
sever
sever
paediatr
studi
demonstr
correl
viru
load
sever
respiratori
infect
analysi
larger
number
infect
patient
andor
differ
spectrum
exacerb
sever
need
demonstr
exclud
associ
copd
patient
furthermor
complet
respiratori
virom
show
high
bacteriophag
abund
could
link
absenc
viral
pathogen
lower
bacteriophag
abund
may
result
viral
expans
hypothet
healthi
virom
size
divers
fit
certain
size
divers
bacteriophag
viral
infect
pathogen
predomin
virom
altern
other
hypothes
viral
microbi
divers
may
play
role
infect
suscept
develop
acut
chronic
respiratori
diseas
result
indic
virom
dysbiosi
may
accompani
bacteriom
dysbiosi
though
signific
differ
detect
line
report
howev
studi
compar
copd
exacerb
without
viral
infect
other
found
higher
phage
abund
patient
sever
copd
compar
one
patient
moder
copd
healthi
control
dna
sequenc
line
hypothesi
state
dysbiosi
increas
diseas
progress
copd
patient
viral
infect
suggest
trigger
bacteri
overgrowth
infect
demonstr
signific
viralbacteri
interact
moreov
hypothet
bacteriophag
play
role
horizont
gene
transfer
bacteri
virul
factor
abund
bacteri
phyla
detect
studi
compar
report
although
percentag
proteobacteria
rel
high
compar
studi
nasopharyng
microbiom
swab
sampl
copd
exacerb
studi
lower
airway
mean
eg
protect
brush
bronchoscopi
need
analysi
bacteri
viral
sub
popul
includ
comparison
pcr
cultur
result
studi
compar
respiratori
virom
stabl
diseas
exacerb
need
determin
potenti
correl
viromebacteriom
stabl
state
diseas
progress
exacerb
frequenc
current
studi
respiratori
pathogen
detect
rna
virus
line
previou
literatur
howev
must
note
despit
fact
wide
rang
dna
virus
detect
current
protocol
dna
bacteriophag
high
abund
herp
simplex
viru
bocaviru
anellovirus
cmv
ki
polyomaviru
exclud
suboptim
detect
dna
virus
furthermor
highli
diverg
virus
sequenc
deviat
repres
ncbi
refseq
sequenc
may
miss
describ
other
howev
bioinformat
classif
use
altern
databas
genomedetect
local
databas
result
addit
find
though
mng
render
possibl
detect
virus
direct
respiratori
materi
revolutionari
method
yet
use
routin
accredit
diagnost
procedur
pathogen
detect
mng
implement
routin
diagnost
optim
protocol
must
defin
analysi
interpret
metagenom
data
must
standard
follow
extern
qualiti
assess
studi
demonstr
good
perform
mng
protocol
line
studi
seem
overcom
current
threshold
implement
clinic
diagnost
mng
protocol
use
highli
sensit
specif
semiquantit
detect
respiratori
pathogen
virus
excel
neg
predict
valu
implic
potenti
mng
exclud
known
viral
infecti
caus
one
test
consequ
clinic
decis
make
reduc
abund
bacteriophag
copd
patient
viral
pathogen
implic
skew
virom
specul
bacteri
popul
infect
